...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What's the deal with Zenith?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

ZCC could buy a boat load of RVX shares at todays prices for next to nothing and have control of the company RVX which may be good.

Existing RVX shareholders would get diluted accordingly, no? Unless there were a willing seller at today's prices which I can't imagine anyone lining up to sell at 10 cents.

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply